From: DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review
Ref. | N | Mean age (SD) | Sex (FÂ %) | Method | Subgroup analyses /covariates | RESULTS: methylation loci | |||
---|---|---|---|---|---|---|---|---|---|
 | BD | HC | BD | HC | BD | HC |  |  |  |
Bromberg et al., 2009 [42] | 49 | 27 | 39 (13) | 42 (10) | 41 | 37 | Radiolabeled [3H] cytosine-extension assay a, c, d | Medication (valproate) h, sex h, smoking h, duration of illness h, family history of BD h | No global methylation differences h |
Carlberg et al., 2014 [43] | 60 | 278 | 42 (15) | 32 (4) | 45 | 62 | MethyLight b, c, d | Age g, gender h, clinical variables, genotype h | No difference in methylation of BDNF (exon I promoter) h |
D’Addario et al., 2012 [44] | 94 | 52 | 52 (12) | - | 60 | - | Fluorescence-based real-time PCR b, c, d | Medication e, BD-I compared to BD-II h, mood state h | Hypermethylation of BDNF (exon I promoter) e only in BD-II; Higher methylation associated with mood stabiliser and antidepressants, but lower for lithium and valproate |
Dell’Osso et al., 2014 [45] | 111 | 44 | - | - | - | - | Fluorescence-based real-time PCR b, c, d | Age h, sex h, mood state e, medication, BD-I compared to BD-II | Hypermethylation of BDNF (exon I promoter) e in BD-II compared to BD-I; Higher methylation in depressed compared to manic/mixed states; Higher methylation in BD-II males with increasing age |
Kaminsky et al., 2012 [46] | 370 | 382 | 43 (11) | 42 (6) | 58 | 55 | Pyrosequencing b, c, d | Age e, sex, genotype f, medication (mood stabiliser) e | HCG9 (first exon extending into the first intron) f in BD (when controlling for age and genotype); Higher methylation in BD/HC with increasing age; Lower methylation in GG allele compared to GA allele carriers; Higher mood stabiliser dose increases methylation towards HC levels |
Kuratomi et al., 2008 [47] | 23 | 18 | 57 (11) | 46 (12) | 52 | 33 | Pyrosequencing b, c, d | Age h, sex e, medication (valproate) h, BD-I compared to BD-II f | Differential methylation of SMS (5'region) g, higher methylation for females in BD-I/II group compared to HC; Hypomethylation of PPIEL (promoter and 5'region) f for BD-II compared to BD-I; No difference in methylation of PIP5KL1 h, ARMC3 h |
Sugawara et al., 2011 [48] | 20 | 20 | 39 (13) | 39 (9) | 60 | 20 | Pyrosequencing b, c, d | - | Differential methylation of SLC6A4 (promoter) g, higher methylation in CpG 3 and 4 for BD compared to HC |